Evidence map›Paper›PMID 25579865›Full record

Trial reportMetabolism: clinical and experimental2015

Activation of innate immunity modulates insulin sensitivity, glucose effectiveness and pancreatic β-cell function in both African ancestry and European ancestry healthy humans.

Jane F Ferguson, Rhia Y Shah, Rachana Shah, Nehal N Mehta, Michael R Rickels, Muredach P Reilly

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Metabolism: clinical and experimental, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Jane F Ferguson *Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Rhia Y Shah *Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Rachana ShahDivision of Pediatric Endocrinology, Children's Hospital, Philadelphia, PA, USA.
Nehal N MehtaNational Heart, Lung and Blood Institute, Bethesda, MD, USA.
Michael R RickelsInstitute for Diabetes, Obesity & Metabolism, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Muredach P ReillyCardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Cardiovascular Institute of the South · USChildren's Hospital of Philadelphia · USNational Heart Lung and Blood Institute · USUniversity of Pennsylvania · US

Funding

VIRAL VECTOR COREP30DK019525 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MITCHELL A. LAZAR · 1986 to 2026
$48.3M
Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
The Nicotinic Acid Receptor HM74A in Vascular InjuryP50HL083799 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2010
$15.8M
Elucidation of Tissue-Specific Transcriptomic Profiles in Cardiometabolic DiseaseR01HL113147 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LI, MINGYAO, REILLY, MUREDACH P · 2012 to 2022
$6.8M
Fractalkine in Adipose Inflammation and Insulin ResistanceR01DK090505 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI REILLY, MUREDACH P · 2011 to 2015
$2.8M
Translational Studies of ADAMTS7 a Novel GWAS Locus for Coronary AtherosclerosisR01HL111694 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI REILLY, MUREDACH P · 2012 to 2015
$2.4M
Glycomics of Heart and Lung Disease in the Genomic EraU01HL108636 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI REILLY, MUREDACH P · 2011 to 2014
$2.4M
Mentored Patient Oriented Research in Cardiometabolic DiseaseK24HL107643 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI REILLY, MUREDACH P · 2011 to 2020
$1.4M
Omega-3 PUFA suppress adipochemokines in human obesityK23DK095913 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI SHAH, RACHANA · 2013 to 2015
$436k
NCATS NIH HHS UL1 TR000003NCATS NIH HHS UL1TR000003NHLBI NIH HHS K24 HL107643NHLBI NIH HHS K24-HL-107643NHLBI NIH HHS P50 HL083799NHLBI NIH HHS P50-HL-083799NHLBI NIH HHS R01 HL111694NHLBI NIH HHS R01-HL-111694NHLBI NIH HHS R01 HL113147NHLBI NIH HHS R01-HL-113147NHLBI NIH HHS U01 HL108636NHLBI NIH HHS U01-HL-108636NIDDK NIH HHS K23 DK095913NIDDK NIH HHS P30 DK019525NIDDK NIH HHS P30-DK19525NIDDK NIH HHS R01 DK090505NIDDK NIH HHS R01-DK-090505
6 · The paper itself

Abstract

objectiveInsulin resistance is a risk factor for type 2 diabetes, and is associated with inflammatory cardiometabolic disease. Given differences between African ancestry (AA) and European ancestry (EA) in the epidemiology of type 2 diabetes as well as in response to inflammatory stress, we investigated potential race differences in glucose homeostasis responses during experimental endotoxemia in humans.

methodsHealthy volunteers (age 18-45 years, BMI 18-30 kg/m(2), 47% female, African-ancestry (AA, n=42) and European-ancestry (EA, n=106)) were recruited as part of the Genetics of Evoked Responses to Niacin and Endotoxemia (GENE) Study. Subjects underwent an inpatient endotoxin challenge (1 ng/kg LPS) and two frequently-sampled intravenous glucose tolerance tests (FSIGTT). Insulin and glucose values obtained during FSIGTT pre- and 24-hours post-LPS were analyzed using the minimal model.

resultsFSIGTT derived insulin sensitivity index (SI), disposition index (DI) and glucose effectiveness (SG) decreased significantly following LPS (p<0.0001) while the acute insulin response to glucose (AIR(g)) increased (p<0.0001). Although expected race differences were observed in glucose homeostasis parameters at baseline prior to LPS e.g., lower SI (2.5 vs. 4.1 μU/L/min, p<0.0001) but higher AIR(g) (median 848 vs. 290 μU/L/min, p<0.0001) in AA vs. EA, the changes in glucose homeostasis responses to LPS were directionally and proportionally consistent across race e.g., SI median -35% in EA and -29% in AA and AIR(g) median +17% in EA and +26% in AA.

conclusionBoth EA and AA samples modulated glucose and insulin homeostasis similarly during endotoxemia. IMPLICATIONS: Race differences in response to environmental inflammatory stress are unlikely to be a substantial contributor to the observed difference in diabetes incidence and complications between EA and AA.

Indexed as

Black PeopleWhite PeopleAdolescentAdultFemaleGlucoseGlucose Tolerance TestHumansImmunity, InnateInsulin ResistanceInsulin-Secreting CellsLipopolysaccharidesMaleMiddle AgedYoung AdultGlucoseLipopolysaccharidesGlucose effectivenessInsulin sensitivityLPSRace differences

Identifiers

PMID25579865
PMCPMC4346476
OpenAlexW2047451581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.